Babushahi.com

Baljit Balli, Editor

NEWS FLASH
May 21, 2022Punjab Dairy farmers end protest after assurance from government (Watch Video also) May 21, 2022J-K tunnel collapse: Rescue operation concludes, total of 10 bodies recovered May 21, 2022Delhi: 1 killed, 2 injured in Dwarka wall collapse May 21, 2022Stunner Hina Khan slays in satin golden gown at Cannes May 21, 2022Haryana: 3 workers killed in fire mishap at Faridabad factory May 21, 2022Death toll rises to 9 in J-K tunnel collapse May 21, 2022Main accused arrested in Ludhiana Court Blast case May 21, 2022Trials for Sports Wing at State School of Sports Jalandhar on these dates May 21, 2022Moong crop sowing in Punjab ends with new record, 7000 acres areas increased than previous season May 21, 2022Insurance companies should not be too technical while settling claims, says SC May 21, 2022India’s famous violinist Dr.Sujit Kumar gives melodic touch to Musical Evening at VWS May 21, 2022Indian high commission in Canada issues advisory after drowning deaths May 21, 2022Easyday asked to refund Rs 4, pay Rs 2000 compensation to a buyer; Here's why May 21, 2022Petrol & Diesel gets cheaper; Read details May 21, 2022DGP Punjab chairs high-level meetings in Amritsar & Jalandhar, reviews law & order and crime situation

Corona-June 2021

Bharat Biotech shares full data of all research studies of Covaxin

By : Agency

First Published : Saturday, Jun 12, 2021 07:21 PM
2. Twitter
3. Whatsapp
4. Send Email
  
  ×
  Email this news
5. Print
6. ← Go Back
- Twitter
- Whatsapp
- Send Email
  
  ×
  Email this news
- Print
- ← Go Back
- Photo Source: ANI
  
  Bharat Biotech shares full data of all research studies of Covaxin
  
  New Delhi, June 12, 2021 (ANI): Bharat Biotech on Saturday shared full data of all research studies of its Covaxin-- India's first indigenous COVID-19 vaccine. As per the company officials, the complete data for Phase I and II, and partial data for Phase III trials of Covaxin have been thoroughly scrutinised by the regulators in India.
  
  In a timely approach to peer review, the company has already published as many as nine research studies on the safety and efficacy of Covaxin in five globally reputed peer-reviewed journals in a span of just twelve months.
  
  Covaxin, a whole-virion inactivated coronavirus vaccine, has many firsts to its credit in data transparency. It is the first and only product to have published any data from human clinical trials in India.
  
  Covaxin is the only product to have any data on emerging variants and it is also the first and only COVID-19 vaccine to have efficacy data in Indian populations, Bharat Biotech said in a statement. In vaccine development, preclinical studies involve the testing of vaccine candidates in laboratory animals.
  
  Bharat Biotech completed three preclinical studies, which are published in Cellpress, a peer-reviewed journal. The studies on Covaxin's Phase I (done to assess a vaccine's safety, immune response and to determine right dosage), and Phase II clinical trial (carried out to assess the safety and the ability of the vaccine to generate an immune response) are published by the peer-reviewed journal- the "Lancet-Infectious Diseases", read the statement.
  
  The company said that the full data from studies on Covaxin's neutralization of variants are already published at "bioRxiv", Clinical Infectious Diseases, and Journal of Travel Medicine.
  
  "The study on the neutralisation of Beta and Delta variants (B.1.351 and B.1.617.2 respectively) and the study on B1.1.28 variant, at Journal of Travel Medicine, while the studies on B.1.617 variant and Alpha variant (B.1.1.7) are published at Clinical Infectious Disease, and Journal of Travel Medicine respectively," it said.
  
  "The published studies are widely cited for the rigour and breadth that Bharat Biotech brings to its clinical trials. Currently, data from both efficacy and safety follow-up of Covaxin's Phase III trial is being analyzed and compiled. Upholding its uncompromising commitment to integrity, the company will make Phase III trials data from the final analysis public soon," read the statement.
  
  India had begun its COVID-19 vaccination drive on January 16, 2021, with two vaccines- Covaxin and Serum Insitute of India's Covishield. (ANI)
2. Twitter
3. Whatsapp
4. Send Email
  
  ×
  Email this news
5. Print
6. ← Go Back
- Twitter
- Whatsapp
- Send Email
  
  ×
  Email this news
- Print
- ← Go Back
Related News
Top News VIEW ALL
[ VIEW ALL TOP NEWS ]
Blogs/Opinion VIEW ALL
- Transition time in society: Journey from son preference to DINK culture, read views of Dr. Amandeep Aggarwal
- 1. Dr Amandeep Aggarwal Family Physician
- Conspicuous by Absence: Maturity in Sikh Clergy
- 1. Pushpinder Singh Gill Professor, School of Management Studies Punjabi University Patiala
- Do not waste time on social media....by Gurjot Singh Kaler
- 1. Gurjot Singh Kaler The writer is Superintendent of Police (SP), Punjab
- World Homoeopathy Day: Understanding Homeopathy & its significance...... by Dr. Ravinder Kaur Bawa
- 1. Dr. Ravinder Kaur Bawa The writer is Homeopathy Specialist
- Tight Rope Walk Amidst Political Cacophony.......by Pushpinder Singh Gill
- 1. Pushpinder Singh Gill The writer is a Professor, School of Management Studies, Punjabi University Patiala.
[ VIEW ALL OPINIONS ]
Polls
- Will Punjab AAP's 'Janta Budget' help solve the state's problems?
- Posted on: 2022-05-13
- Yes
  
  No
  
  Cant say
- 1. SHOW RESULTS
  2. OLDER POLL RESULTS
- Poll Results
  
  Total Responses : 106
  
  Yes : 83
  
  No : 17
  
  Cant say : 6
  
  Facebook
  
  Twitter
  
  Whatsapp
  
  Send Email
  
  ×
  Email this news
Do you Know ?
[ VIEW ALL ]
Word of the Day
No of visitors Babushahi.com

2 2 7 8 8 9 0 3
Babushahi-Data Bank
- Tirchhi Nazar
- Baljit Balli
  
  Editor
- A French woman's email took me back 26 years ........ Baljit Balli
- Read More
Special Edition
Books / Literature
- Former IAS officer Vivek Atre releases book of English poems written by 12-year-old Prisha
[ CONTINUE READING ]
From Social Media
- What is required for De-Spamming of Twitter, read what Analyst says
[ VIEW ALL SOCIAL MEDIA ]

© Copyright All Rights Reserved to Babushahi.com Project Development by Hambzik International, B.C. Canada